SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biogen
BIIB 159.65+2.2%3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Walkingshadow who wrote (1038)6/13/1999 1:03:00 AM
From: SDR-SI  Read Replies (1) of 1686
 
WS:

My quick post to summarize a few highlights of Friday's Biogen Annual Meeting at:

Message 10083808

does not really do justice to either the management presentations or the research presentations.

It would be hard for someone to have attended the meeting and not come away with the feeling that this is a company that knows exactly where it wants to go and exactly how to get there. This derives not only from its ability to make the transition from biotech boutique to successful marketer, nor just from the clear economic, therapeutic and service success of its first self-marketed product, nor just from the impressive research program, but also from the company having reached the point of development where it can provide for its future leadership from the growth and development of own internal resources.

Whether BGEN fits into your personal investment requirements is something that you must determine yourself from your own DD, but it is certainly a candidate worth screening.

Steve
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext